Written by: Stephen Hsu
Primary Source: Information Processing
Say what you want about Trump, he’s one of the only candidates who isn’t beholden to oligarch campaign contributors. Below he goes after the crazy tax break that hedge fund managers enjoy.
Bloomberg: … “I know a lot of bad people in this country that are making a hell of a lot of money and not paying taxes,” Trump said in an interview with Time, in apparent reference to hedge fund and private equity fund managers. “The tax law is totally screwed up.”
“They’re paying nothing and it’s ridiculous,” he added on CBS a few days later. “The hedge fund guys didn’t build this country. These are guys that shift paper around and they get lucky.” He went on: “They’re energetic, they’re very smart. But a lot of them, it’s like they’re paper pushers. They make a fortune, they pay no tax… The hedge funds guys are getting away with murder.”
Trump was apparently referring to carried interest. Most hedge funds and private equity funds are structured as partnerships where the fund managers serve as general partners and the investors as limited partners. Carried interest represents the fund managers’ share of the income generated by the fund, which is typically 20 percent of the fund’s profits at the end of the year. For most funds, this share of the profits, called an “incentive fee,” makes up most of the fund managers’ income, and, depending on the size and performance of the fund, it can stretch into the hundreds of millions of dollars. It’s largely what pays for 40,000 square foot mansions in Greenwich, Conn., and major league baseball teams and $100 million works of art. Under current tax rules, much of that incentive fee income is taxed at the long-term capital gains rate of 20 percent. If it was taxed as ordinary income, the top rate would be 39.6 percent. For hedge fund managers, the carried interest tax provision is something of a third rail, the one thing that unites them in furious opposition.
Latest posts by Stephen Hsu (see all)
- MSU Research Update (video) - April 17, 2019
- Interview with Genetic Engineering & Biotechnology News - April 17, 2019
- Precision Genomic Medicine and the UK - February 15, 2019